Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer.

被引：0
|
作者：
Olson, E. M. [1 ]
Flores, L. M. [1 ]
Najita, J. S. [1 ]
Curley, C. [1 ]
Jeong, J. [1 ]
Murray, K. [1 ]
Savoie, J. J. [1 ]
Winer, E. P. [1 ]
Krop, I. E. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P005-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P005-07
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [11] Tolerability of neratinib in older adults with HER2 positive or HER2 mutated metastatic breast cancer.
    Lee, Jin Sun
    Yost, Susan Elaine
    Stiller, Tracey
    Blanchard, Suzette
    Padam, Simran
    Katheria, Vani
    Tang, Aileen
    Martinez, Norma
    Patel, Niki Himat
    Sedrak, Mina S.
    Waisman, James Ross
    Li, Daneng
    Sanani, Shamel
    Presant, Cary A.
    Mortimer, Joanne E.
    Yuan, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [12] EFFICACY OF LAPATINIB (L) IN METASTATIC BREAST CANCER (MBC) PATIENTS (PTS) WITH HER2 NEGATIVE (-) PRIMARY TUMORS (PT) AND HER2 POSITIVE (+) CIRCULATING TUMOR CELLS (CTC)
    Pestrin, M.
    Bessi, S.
    Minisini, A. M.
    Masci, G.
    Cascinu, S.
    Ravaioli, A.
    Di Marsico, R.
    Tondini, C.
    Buyse, M.
    Di Leo, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 41 - 41
  • [13] Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
    Fehm, Tanja
    Becker, Sven
    Duerr-Stoerzer, Silke
    Sotlar, Karl
    Mueller, Volkmar
    Wallwiener, Diethelm
    Lane, Nancy
    Solomayer, Erich
    Uhr, Jonathan
    BREAST CANCER RESEARCH, 2007, 9 (05) : R74
  • [14] Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
    Tanja Fehm
    Sven Becker
    Silke Duerr-Stoerzer
    Karl Sotlar
    Volkmar Mueller
    Diethelm Wallwiener
    Nancy Lane
    Erich Solomayer
    Jonathan Uhr
    Breast Cancer Research, 9
  • [15] HER2 TUMOR HETEROGENEITY AND DISCREPANCIES IN HER2 STATUS BETWEEN PRIMARY TUMOR AND CORRESPONDING CIRCULATING TUMOR CELLS IN METASTATIC BREAST CANCER PATIENTS
    Migliaccio, I.
    Galardi, F.
    Bessi, S.
    Capaccioli, G.
    Biagioni, C.
    Truglia, M.
    Santarpia, L.
    Giannini, A.
    Di Leo, A.
    Pestrin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 25 - 25
  • [16] Prognostic role of plasma HER2 gene copy number in patients with HER2 positive metastatic breast cancer.
    Ran, Ran
    Huang, Wenfa
    Lin, Shao
    Niu, Yunyun
    Rugo, Hope S.
    Kong, Weiyao
    Bo, Shiping
    Lu, Sijia
    Li, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [17] The HER2 circulating ratio to define HER2 expressing circulating tumor cells in advanced breast cancer
    D'Amico, Paolo
    Gerratana, Lorenzo
    Shah, Ami
    Zhang, Qiang
    Davis, Andrew
    Zhang, Youbin
    Jacob, Saya
    Vagia, Elena
    Behdad, Amir
    Reduzzi, Carolina
    Curigliano, Giuseppe
    Cristofanilli, Massimo
    CANCER RESEARCH, 2021, 81 (04)
  • [18] Successful targeting HER2 in heavily pretreated HER2-negative metastatic breast cancer patients presenting with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells
    Kurbacher, C. M.
    Quade, A.
    Eichler, C.
    Kunstmann, G.
    Herz, S.
    Kurbacher, J. A.
    Warm, M. R.
    CANCER RESEARCH, 2016, 76
  • [19] HER2 overexpressing metastatic breast cancer.
    Spigel D.R.
    Burstein H.J.
    Current Treatment Options in Oncology, 2002, 3 (2) : 163 - 174
  • [20] Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor
    Beije, Nick
    Onstenk, Wendy
    Kraan, Jaco
    Sieuwerts, Anieta M.
    Hamberg, Paul
    Dirix, Luc Y.
    Brouwer, Anja
    de Jongh, Felix E.
    Jager, Agnes
    Seynaeve, Caroline M.
    Van, Ngoc M.
    Foekens, John A.
    Martens, John W. M.
    Sleijfer, Stefan
    NEOPLASIA, 2016, 18 (11): : 647 - 653
12345